Initial comparison of descriptive statistics for all clinical variables was performed using either analysis of variance or chi-squared tests, depending on whether the variables were quantitative or categorical. To allow comparison among studies, the ARCS scores were then standardized (to Z scores) using the mean and SD of the normal population reported by Schofield et al. 21 Bivariate linear correlation analysis of standardized ARCS scores was performed using Pearson’s (r) coefficient tests. Because moderate outliers were observed for some of the cognitive variables, we performed a secondary check of the Pearson’s correlation analyses by using Spearman’s (rho) tests, which are robust to outlier effects. These tests yielded results showing consistent strength and significance for all bivariate tests, thus adding confidence that the Pearson’s (r) results were not affected by outliers. For each regression model, we entered each of the mental health measures as the main effect factors so as to approximate the relative contribution of each mental health factor on cognitive function while accounting for the others. Tests for normality of outcome variables were performed using Q-Q plots and Kolmogorov-Smirnov goodness-of-fit tests. These tests showed some modest deviations from normality for language and visual domains, but these were not deemed substantial enough to warrant transformation. e., sex, age at initial assessment, age at diagnosis, disease duration, EDSS, treatment type, MS subtype, annual relapse rate, other mental health medications, and education level. To account for multicolinearity, and so as not to overburden each regression model with too many uninformative parameters, we chose to include all main effect factors and covariates in a step-wise fashion using an algorithm that only retained covariates if they contributed to the overall regression model (p<0.05). In an effort to discern the relative association of the three mood indices from each other, and in relation to the other clinical covariates, we partitioned our regression models to include forced entry of each mood index separately, with all other clinical covariates entered in a step-wise fashion, and forced entry of all three mood indices combined, with all other clinical covariates entered in a step-wise fashion. Because we tested six different hypotheses (i.e., six cognitive function outcomes), we used the Bonferroni correction method to adjust the significance level to 0.008 (i.e., 0.05/6). In addition, we retained results at the “suggestive” level of 0.05 to provide an indication of association trends.
This new descriptive properties with the MS subtypes receive into the Dining table 1. Seventy-9 % of our own cohort was indeed classified as the relapsing remitting (RRMS), 14% was in fact additional modern (SPMS), and 7% priS) MS. People searching MS-particular immunomodulatory services was indeed mostly RRMS clients and you may was acquiring interferon beta (N=89), glatiramer acetate (N=42), natalizumab (N=25), fingolimod (N=9), dimethyl fumarate (N=4), if any MS immunomodulatory treatment (N=153) at the time of performing the analysis examination. SPMS people was older, got an extended lifetime of state, along with increased EDSS level than just the RRMS competitors during the enough time of one’s assessments. Utilising the severity progressing criteria for every mood list into DASS, twenty four the severity of emotional symptoms is actually examined. Inside our MS cohort, 12% from people said really serious otherwise very serious nervousness, with fourteen% scoring modest quantities of stress (Shape 1). Thirty-1 percent were undergoing treatment that have a serotonin reuptake inhibitor during the enough time from carrying out cognitive assessment. Centered on our definition of intellectual impairment (see a lot more than), 34% of our own MS cohort were cognitively impaired.
Figure step 1. Shipping from Mood Indices in the Numerous Sclerosis (MS) Cohort Proving Dimensions of People at each Number of Severity a